Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo

References

• Zhang N, Yin Y, Xu SJ, Chen WS. 5-Fluorouracil: Mechanisms of resistance and reversal strategies. Molecules 2008; 13:1551-69; PMID:18794772; https://doi.org/10.3390/molecules13081551
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3:330-8; PMID:12724731; https://doi.org/10.1038/nrc1074
   PubMed Web of Science ®Google Scholar
• Noordhuis P, Holwerda U, Van der Wilt CL, Van Groeningen CJ, Smid K, Meijer S, Pinedo HM, Peters GJ. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol 2004; 15:1025-32; PMID:15205195; https://doi.org/10.1093/annonc/mdh264
   PubMed Web of Science ®Google Scholar
• Diasio RB, Beavers TL, Carpenter JT. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J Clin Invest 1988; 81:47-51; PMID:3335642; https://doi.org/10.1172/JCI113308
   PubMed Web of Science ®Google Scholar
• Pillai G, Ceballos-Coronel ML. Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists. SAGE Open Med 2013; 1:2050312113513759; PMID:26770691; https://doi.org/10.1177/2050312113513759
   PubMedGoogle Scholar
• Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012; 14:1-16; PMID:22524388; https://doi.org/10.1146/annurev-bioeng-071811-150124
   PubMed Web of Science ®Google Scholar
• Gabizon AA. Liposomal drug carrier systems in cancer chemotherapy: Current status and future prospects. J Drug Target 2002; 10:535-8; PMID:12683720; https://doi.org/10.1080/1061186021000043061
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Storm G. Liposomal nanomedicines as anticancer therapeutics: Beyond targeting tumor cells. Int J Pharm 2008; 364:258-64; PMID:18773947; https://doi.org/10.1016/j.ijpharm.2008.08.005
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65:271-84; PMID:10699287; https://doi.org/10.1016/S0168-3659(99)00248-5
   PubMed Web of Science ®Google Scholar
• Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011; 63:131-5; PMID:20304019; https://doi.org/10.1016/j.addr.2010.03.011
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Fens MH, Janssen AP, Molema G, Storm G. Liposomal targeting of angiogenic vasculature. Curr Drug Deliv 2005; 2:363-8; PMID:16305439; https://doi.org/10.2174/156720105774370186
   PubMedGoogle Scholar
• Sylvester B, Porfire A, Muntean DM, Vlase L, Luput L, Licarete E, Sesarman A, Alupei MC, Banciu M, Achim M, et al. Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach. J Liposome Res 2016:1-13; PMID:27788618; https://doi.org/10.1080/08982104.2016.1254242. [Epub ahead of print].
   PubMedGoogle Scholar
• Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Mitsuyama S, Iwao H, Arakawa T. AP-1 and colorectal cancer. Inflammopharmacology 2005; 13:113-25; PMID:16259733; https://doi.org/10.1163/156856005774423935
   PubMedGoogle Scholar
• Bossy-Wetzel E, Bakiri L, Yaniv M. Induction of apoptosis by the transcription factor c-Jun. EMBO J 1997; 16:1695-709; PMID:9130714; https://doi.org/10.1093/emboj/16.7.1695
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009; 15:2248-58; PMID:19276252; https://doi.org/10.1158/1078-0432.CCR-08-1383
   PubMed Web of Science ®Google Scholar
• Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11:805-15; PMID:7308288; https://doi.org/10.1002/eji.1830111013
   PubMed Web of Science ®Google Scholar
• Kou XX, Li CS, He DQ, Wang XD, Hao T, Meng Z, Zhou YH, Gan YH. Estradiol promotes M1-like macrophage activation through cadherin-11 to aggravate temporomandibular joint inflammation in rats. J Immunol 2015; 194:2810-8; PMID:25681337; https://doi.org/10.4049/jimmunol.1303188
   PubMed Web of Science ®Google Scholar
• Banciu M, Metselaar JM, Schiffelers RM, Storm G. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia 2008; 10:108-17; PMID:18283332; https://doi.org/10.1593/neo.07913
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15:316-28; PMID:16054557; https://doi.org/10.1016/j.numecd.2005.05.003
   PubMed Web of Science ®Google Scholar
• Licarete E, Sesarman A, Banciu M. Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems. J Microencapsul 2015; 32:619-31; PMID:26299551; https://doi.org/10.3109/02652048.2015.1073383
   PubMed Web of Science ®Google Scholar
• Patras L, Sesarman A, Licarete E, Luca L, Alupei MC, Rakosy-Tican E, Banciu M. Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration. Oncol Lett 2016; 12:1183-91; PMID:27446416; https://doi.org/10.3892/ol.2016.4708
   PubMed Web of Science ®Google Scholar
• Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM 3rd, Mackay S. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 2001; 130:363-9; PMID:11490372; https://doi.org/10.1067/msy.2001.116672
   PubMed Web of Science ®Google Scholar
• Wang H, Birkenbach M, Hart J. Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis 2000; 21:1313-7; PMID:10874008; https://doi.org/10.1093/carcin/21.5.313
   PubMed Web of Science ®Google Scholar
• Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005; 8:299-309; PMID:16226705; https://doi.org/10.1016/j.ccr.2005.09.005
   PubMed Web of Science ®Google Scholar
• Igney FH, Krammer PH. Tumor counterattack: Fact or fiction? Cancer Immunol Immunother 2005; 54:1127-36; PMID:15889255; https://doi.org/10.1007/s00262-005-0680-7
   PubMed Web of Science ®Google Scholar
• Nai YJ, Jiang ZW, Wang ZM, Li N, Li JS. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice. JPEN J Parenter Enteral Nutr 2007; 31:18-25; PMID:17202436; https://doi.org/10.1177/014860710703100118
   PubMed Web of Science ®Google Scholar
• Nowis D, McConnell EJ, Dierlam L, Palamarchuk A, Lass A, Wojcik C. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response. Int J Cancer 2007; 121:431-41; PMID:17373661; https://doi.org/10.1002/ijc.22695
   PubMed Web of Science ®Google Scholar
• Salven P, Ruotsalainen T, Mattson K, Joensuu H. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 1998; 79:144-6; PMID:9583728; https://doi.org/10.1002/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995; 55:3964-8; PMID:7664263. Available from: http://cancerres.aacrjournals.org/content/55/18/3964.full-text.pdf
   PubMed Web of Science ®Google Scholar
• Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 2006; 66:9705-13; PMID:17018629; https://doi.org/10.1158/0008-5472.CAN-06-2105
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med 2015; 212:435-45; PMID:25753580; https://doi.org/10.1084/jem.20150295
   PubMed Web of Science ®Google Scholar
• Cook J, Hagemann T. Tumour-associated macrophages and cancer. Curr Opin Pharmacol 2013; 13:595-601; PMID:23773801; https://doi.org/10.1016/j.coph.2013.05.017
   PubMed Web of Science ®Google Scholar
• Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, Xie P, Ding JL. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest 2013; 93:844-54; PMID:23752129; https://doi.org/10.1038/labinvest.2013.69
   PubMed Web of Science ®Google Scholar
• Michielsen AJ, Hogan AE, Marry J, Tosetto M, Cox F, Hyland JM, Sheahan KD, O'Donoghue DP, Mulcahy HE, Ryan EJ, et al. Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PLoS One 2011; 6:e27944; PMID:22125641; https://doi.org/10.1371/journal.pone.0027944
   PubMed Web of Science ®Google Scholar
• Stanilov N, Miteva L, Stankova N, Jovchev J, Deliyski T, Stanilova S. Role of IL-12P40 and IL-10 in progression of colorectal cancer. Khirurgiia (Sofiia) 2010; 4-5:26-9; PMID:21972680. Available from: http://tru.uni-sz.bg/tsj/vol8,Suppl.2,2010/N.Stanilov.pdf.
   PubMedGoogle Scholar
• Bien E, Krawczyk M, Izycka-Swieszewska E, Trzonkowski P, Kazanowska B, Adamkiewicz-Drozynska E, Balcerska A. Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas. Biomarkers 2013; 18:204-15; PMID:23557126; https://doi.org/10.3109/1354750X.2013.764351
   PubMed Web of Science ®Google Scholar
• Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011; 19:31-44; PMID:21215706; https://doi.org/10.1016/j.ccr.2010.11.009
   PubMed Web of Science ®Google Scholar
• Qi XF, Kim DH, Yoon YS, Kim SK, Cai DQ, Teng YC, Shim KY, Lee KJ. Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells. Toxicol Lett 2010; 199:277-87; PMID:20883752; https://doi.org/10.1016/j.toxlet.2010.09.010
   PubMed Web of Science ®Google Scholar
• Luput L, Licarete E, Sesarman A, Laura P, Alupei MC, Banciu M. Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner. Oncol Rep 2017; 37:2472-80; PMID:28260079; https://doi.org/10.3892/or.2017.5466
   PubMed Web of Science ®Google Scholar
• Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, Rose-John S, Neurath MF. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 2005; 4:217-20; PMID:15655344; https://doi.org/10.4161/cc.4.2.1413
   PubMed Web of Science ®Google Scholar
• Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, Syrjanen K, Collan Y, Pyrhönen S. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res 2008; 28:3865-70; PMID:19192642. Available from: http://ar.iiarjournals.org/content/28/6B/3865.long.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez RR, Lanier V, Newman G. Leptin's pro-angiogenic signature in breast cancer. Cancers (Basel) 2013; 5:1140-62; PMID:24202338; https://doi.org/10.3390/cancers5031140
   PubMedGoogle Scholar
• Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity 2010; 32:593-604; PMID:20510870; https://doi.org/10.1016/j.immuni.2010.05.007
   PubMed Web of Science ®Google Scholar
• Guerriero E, Capone F, Rusolo F, Colonna G, Castello G, Costantini S. Dissimilar cytokine patterns in different human liver and colon cancer cell lines. Cytokine 2013; 64:584-9; PMID:24064000; https://doi.org/10.1016/j.cyto.2013.09.002
   PubMed Web of Science ®Google Scholar
• Pucci S, Mazzarelli P, Sesti F, Boothman DA, Spagnoli LG. Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression. Cell Cycle 2009; 8:473-81; PMID:19177010; https://doi.org/10.4161/cc.8.3.7652
   PubMed Web of Science ®Google Scholar
• Boonyong C, Pattamadilok C, Suttisri R, Jianmongkol S. Benzophenones and xanthone derivatives from Garcinia schomburgkiana-induced P-glycoprotein overexpression in human colorectal Caco-2 cells via oxidative stress-mediated mechanisms. Phytomedicine 2017; 27:8-14; PMID:28314481; https://doi.org/10.1016/j.phymed.2017.01.011
   PubMed Web of Science ®Google Scholar
• Alupei MC, Licarete E, Patras L, Banciu M. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress. Cancer Lett 2015; 356:946-52; PMID:25444912; https://doi.org/10.1016/j.canlet.2014.11.010
   PubMed Web of Science ®Google Scholar
• Achim M, Tomuta I, Muntean D, Porfire A, Tefas LR, Patras L, Licarete E, Alupei MC, Vlase L, Banciu M. Optimization and in vitro evaluation of 5-fluorouracil – loaded long – circulating liposomes. Farmacia 2017; 65:82-91. Available from: http://www.revistafarmacia.ro/201701/issue12017art13.html
   Web of Science ®Google Scholar
• Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov AA Jr., Trubetskoy VS, Herron JN, Gentry CA. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994; 1195:11-20; PMID:7918551; https://doi.org/10.1016/0005-2736(94)90003-5
   PubMed Web of Science ®Google Scholar
• Porfire A, Tomuta I, Muntean D, Luca L, Licarete E, Alupei MC, Achim M, Vlase L, Banciu M. Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells. J Liposome Res 2015; 25:261-9; PMID:25487170; https://doi.org/10.3109/08982104.2014.987787
   PubMed Web of Science ®Google Scholar
• Banciu M, Fens MH, Storm G, Schiffelers RM. Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice. J Control Release 2008; 127:131-6; PMID:18291548; https://doi.org/10.1016/j.jconrel.2008.01.008
   PubMed Web of Science ®Google Scholar
• Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, Petrelli NJ, Findlay MP, Seay TE, Atkins JN, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07. J Clin Oncol 2007; 25:2198-204; PMID:17470851; https://doi.org/10.1200/JCO.2006.08.2974
   PubMed Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016; 7:27-31; PMID:27057123; https://doi.org/10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22:229-37; PMID:14657227; https://doi.org/10.1200/JCO.2004.05.113
   PubMed Web of Science ®Google Scholar
• Rayburn ER, Ezell SJ, Zhang R. Anti-inflammatory agents for cancer therapy. Mol Cell Pharmacol 2009; 1:29-43; PMID:20333321; https://doi.org/10.4255/mcpharmacol.09.05
   PubMedGoogle Scholar
• Wang H, Li M, Rinehart JJ, Zhang R. Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: In vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clin Cancer Res 2004; 10:1633-44; PMID:15014014; https://doi.org/10.1158/1078-0432.CCR-0829-3
   PubMed Web of Science ®Google Scholar
• Alupei MC, Licarete E, Cristian FB, Banciu M. Cytotoxicity of lipophilic statins depends on their combined actions on HIF-1alpha expression and redox status in B16.F10 melanoma cells. Anticancer Drugs 2014; 25:393-405; PMID:24441744; https://doi.org/10.1097/CAD.0000000000000065
   PubMed Web of Science ®Google Scholar
• Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177:751-66; PMID:18110453. Available from: http://www.jbc.org/content/177/2/751.short.
   PubMed Web of Science ®Google Scholar